Scientists have developed a new vaccination strategy for malaria — boosting immunity through bites from mosquitoes carrying a genetically engineered version of the parasite that causes malaria.

Nov. 28, 2024 — Researchers analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug ...

Such rapid acquisition, despite limited malaria exposure because of their young age, might be explained if infections by disease-causing EPCR-binding parasites elicit the production of antibodies ...

Immunization with live-attenuated Plasmodium falciparum malaria parasites is an alternative vaccination strategy that has potential to improve protection. Adverse events were similar across the ...

He learned that the malaria parasite thrives inside red blood cells thanks to its knack for crafting crystals, and he set out to study these crystals, later joining forces with a chemistry faculty ...

The team analysed genomes of 724 malaria parasites that evolved in the lab to resist one of 118 different antimalarial compounds. This included both established treatments and new experimental ...

Severe malaria is caused by the parasite Plasmodium falciparum, which infects and modifies red blood cells. These modifications can make the red blood cells stick to the walls of tiny blood ...

By moving the system to different parasite strains and introducing an advanced SLI2 system for additional genomic edits, this work provides compelling evidence for an innovative and rigorous platform ...

ANALYSIS | THE INDEPENDENT & AGENCIES | A study conducted in Uganda has found evidence of partial resistance to Artemisinin; the primary treatment for malaria in young children with severe forms of ...

Microscopy or rapid diagnostic tests (RDTs) are currently used for the diagnosis of malaria in pregnancy but are insensitive to sequestration or low-level parasite burdens, complicating malaria ...

Cerebral malaria (CM) is a complex of syndromes relating ... exist for IE involving a broad array of host receptors and the parasite variant surface antigen PfEMP1. Intravascular immunopathology ...